DLX5
Homeobox protein DLX-5
Also known as: DLX5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56178
- Gene
- DLX5
- Ensembl
- ENSG00000105880
- Chromosome
- 7
- Canonical length
- 289 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of a homeobox transcription factor gene family similiar to the Drosophila distal-less gene. The encoded protein may play a role in bone development and fracture healing. Mutation in this gene, which is located in a tail-to-tail configuration with another member of the family on the long arm of chromosome 7, may be associated with split-hand/split-foot malformation. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
289 residues, UniProt reviewed canonical sequence.
>P56178|DLX5
1 MTGVFDRRVP SIRSGDFQAP FQTSAAMHHP SQESPTLPES SATDSDYYSP TGGAPHGYCS
61 PTSASYGKAL NPYQYQYHGV NGSAGSYPAK AYADYSYASS YHQYGGAYNR VPSATNQPEK
121 EVTEPEVRMV NGKPKKVRKP RTIYSSFQLA ALQRRFQKTQ YLALPERAEL AASLGLTQTQ
181 VKIWFQNKRS KIKKIMKNGE MPPEHSPSSS DPMACNSPQS PAVWEPQGSS RSLSHHPHAH
241 PPTSNQSPAS SYLENSASWY TSAASSINSH LPPPGSLQHP LALASGTLYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DLX5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- skin: 26 nTPM
- endometrium: 13 nTPM
- placenta: 11 nTPM
- basal ganglia: 7.7 nTPM
- cervix: 7.1 nTPM
- hypothalamus: 5.5 nTPM
Single-cell type
- syncytiotrophoblasts: 361 nCPM
- extravillous trophoblasts: 320 nCPM
- endometrial luminal cells: 274 nCPM
- cytotrophoblasts: 199 nCPM
- migrating cytotrophoblasts: 196 nCPM
- endometrial ciliated cells: 163 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 9.4 nTPM
- basal ganglia: 7.7 nTPM
- cerebral cortex: 5.4 nTPM
- amygdala: 3.5 nTPM
- white matter: 2.3 nTPM
- hippocampal formation: 1.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DLX5.
Disease | AllUniProt
Conditions DLX5 is implicated in, by any mechanism.
- Split-hand/foot malformation 1 with sensorineural hearing loss, autosomal recessive (SHFM1D) MIM:220600
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 95 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Split hand-foot malformation 1
- Split hand-foot malformation 1 with sensorineural hearing loss
- DLX5-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0.22
- gnomAD missense Z
- 0.04
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure formation involved in morphogenesis
- BMP signaling pathway
- cell differentiation
- cell population proliferation
- embryonic limb morphogenesis
- embryonic skeletal system development
- endochondral ossification
- epithelial cell differentiation
- face morphogenesis
- inner ear morphogenesis
- nervous system development
- olfactory bulb interneuron differentiation
- olfactory pit development
- osteoblast differentiation
- positive regulation of canonical Wnt signaling pathway
- positive regulation of DNA-templated transcription
- positive regulation of epithelial cell proliferation
- positive regulation of gene expression
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
- roof of mouth development
- skeletal system development
- interneuron axon guidance
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- HMG box domain binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DLX5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DLX5 as an antibody target. Whether an autoantibody or antibody against DLX5 could matter depends on whether native DLX5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DLX5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DLX5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...